Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

ITT for observational data: worst of both worlds?

Stampfer MJ.

Epidemiology. 2008 Nov;19(6):783-4; discussion 789-93. doi: 10.1097/EDE.0b013e318188442e.

PMID:
18813017
[PubMed - indexed for MEDLINE]
2.

The sound and the fury: was it all worth it?

Hoover RN.

Epidemiology. 2008 Nov;19(6):780-2; discussion 789-93. doi: 10.1097/EDE.0b013e318188e21d.

PMID:
18813016
[PubMed - indexed for MEDLINE]
3.

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.

Hernán MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, Manson JE, Robins JM.

Epidemiology. 2008 Nov;19(6):766-79. doi: 10.1097/EDE.0b013e3181875e61.

PMID:
18854702
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J; Women's Health Initiative Investigators.

Am J Epidemiol. 2006 Apr 1;163(7):589-99. Epub 2006 Feb 16.

PMID:
16484450
[PubMed - indexed for MEDLINE]
Free Article
5.

Observational studies, clinical trials, and the women's health initiative.

Prentice RL.

Lifetime Data Anal. 2007 Dec;13(4):449-62. Epub 2007 Oct 18. Review.

PMID:
17943443
[PubMed - indexed for MEDLINE]
6.

Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial".

Willett WC, Manson JE, Grodstein F, Stampfer MJ, Colditz GA.

Am J Epidemiol. 2006 Jun 1;163(11):1067-8; author reply 1068-9. Epub 2006 Apr 26. No abstract available.

PMID:
16641306
[PubMed - indexed for MEDLINE]
Free Article
7.

What can we learn from design faults in the Women's Health Initiative randomized clinical trial?

Tan O, Harman SM, Naftolin F.

Bull NYU Hosp Jt Dis. 2009;67(2):226-9.

PMID:
19583558
[PubMed - indexed for MEDLINE]
Free Article
8.

[Comments on the Women's Health Initiative (WHI) and the Million Women Study (MWS) which question the usefulness of hormone substitution during menopause].

Lopes P.

J Gynecol Obstet Biol Reprod (Paris). 2003 Oct;32(6):500-2. French. No abstract available.

PMID:
14593295
[PubMed - indexed for MEDLINE]
Free Article
9.

Statistical issues arising in the Women's Health Initiative.

Prentice RL, Pettinger M, Anderson GL.

Biometrics. 2005 Dec;61(4):899-911; discussion 911-41. Review.

PMID:
16401257
[PubMed - indexed for MEDLINE]
10.

Hormone replacement therapy post Women's Health Initiative study: where do we stand?

Calleja-Agius J, Brincat MP.

Curr Opin Obstet Gynecol. 2008 Dec;20(6):513-8. doi: 10.1097/GCO.0b013e32830dfa5c. Review.

PMID:
18989125
[PubMed - indexed for MEDLINE]
11.

Postmenopausal hormone therapy in clinical perspective.

Dören M, Greiser EM.

Menopause. 2008 Jan-Feb;15(1):204-5; author reply 205. No abstract available.

PMID:
18257150
[PubMed - indexed for MEDLINE]
12.

Observational studies and clinical trials of menopausal hormone therapy: can they both be right?

Allison MA, Manson JE.

Menopause. 2006 Jan-Feb;13(1):1-3. No abstract available.

PMID:
16607089
[PubMed - indexed for MEDLINE]
13.

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.

Wittes J, Barrett-Connor E, Braunwald E, Chesney M, Cohen HJ, Demets D, Dunn L, Dwyer J, Heaney RP, Vogel V, Walters L, Yusuf S.

Clin Trials. 2007;4(3):218-34.

PMID:
17715247
[PubMed - indexed for MEDLINE]
14.

Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.

Toh S, Hernández-Díaz S, Logan R, Robins JM, Hernán MA.

Epidemiology. 2010 Jul;21(4):528-39. doi: 10.1097/EDE.0b013e3181df1b69.

PMID:
20526200
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies.

Garbe E, Suissa S.

Hum Reprod. 2004 Jan;19(1):8-13. Review.

PMID:
14688150
[PubMed - indexed for MEDLINE]
Free Article
16.

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Banks E, Canfell K.

Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.

PMID:
19468078
[PubMed - indexed for MEDLINE]
Free Article
17.

How we got to the Women's Health Initiative hormone replacement trial.

Gambone JC.

J Am Osteopath Assoc. 2003 Feb;103(2 Suppl 2):S1-2. No abstract available.

PMID:
12625630
[PubMed - indexed for MEDLINE]
Free Article
18.

Hormone therapy and risk for dementia: where do we go from here?

Maki PM.

Gynecol Endocrinol. 2004 Dec;19(6):354-9. Review.

PMID:
15724810
[PubMed - indexed for MEDLINE]
19.

Women's Health Initiative results: breast cancer risk in perspective.

Kelly PT.

Breast J. 2003 Nov-Dec;9(6):449-51. No abstract available.

PMID:
14616938
[PubMed - indexed for MEDLINE]
20.

Postmenopausal hormone therapy and the risk of cardiovascular disease.

Bittner V.

Expert Opin Pharmacother. 2009 Sep;10(13):2041-53. doi: 10.1517/14656560903066829. Review.

PMID:
19563274
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk